Andrew Thompson

Food and Drug Administration

Medical Devices Are Key to Solving the Healthcare Industry’s Persistent Problems | PR Newswire | 2/4/2020

… also helped the industry put the patient at the center of their business model. In a report published by PwC, Andrew Thompson , co-founder and CEO at Proteus explained that, “The reason why the technology … Inc. (NASDAQ: XRAY ), Tandem Diabetes Care, Inc. (NASDAQ: TNDM ). The Food and Drug Administration (FDA) also recognizes the innovative progress the medical device market has started to go through. Back in 2018, medical device manufacturers …

Follow Andrew Thompson:    

Digital Health

Failing digital health unicorn Proteus severs ties with key pharma partner | Becker’s Hospital Review | 1/15/2020

Only weeks after reports suggested Proteus Digital Health, once valued at $1.5 billion, is struggling to stay afloat, STAT reports the health tech startup has ended a crucial collaboration with Otsuka Pharmaceuticals. Proteus raised a … tech-based treatments for cancer and infectious diseases. Additionally, CEO Andrew Thompson confirmed to STAT that an undisclosed number of employees have been laid off. People familiar with the company and its offerings told STAT …

Mental Health

Failing digital health unicorn Proteus severs ties with key pharma partner | Becker’s Hospital Review | 1/15/2020

mental health conditions. Their sensor-equipped version of antipsychotic drug Abilify was approved by the FDA in 2017. According to STAT , with the premature loss of Otsuka’s funding, Proteus is discontinuing its work in mental illness and cardiovascular conditions, and will focus on attracting payer clients to cover its tech-based treatments for cancer and infectious diseases. Additionally, CEO Andrew Thompson confirmed to STAT that an undisclosed number of employees …

Pear Therapeutics

A forerunner in ‘smart pills’ adopts a new tack as key pharma partnership unravels | STAT | 1/14/2020

… of health conditions have taken their pills. Then, late last year, the company’s funds fell dangerously low . Now, Proteus’ CEO, Andrew Thompson, told STAT that the company and Japanese drug maker Otsuka Pharmaceutical have prematurely … fall, Novartis’ generics unit, Sandoz, ended a deal to commercialize Pear Therapeutics’ smartphone apps for substance use disorders. And last month, Sanofi said it would no longer be involved in running Onduo, its joint venture …

Proteus Digital Health

HCV patients at risk of nonadherence using Proteus’ digital pill achieve sustained viral clearance | MobiHealthNews | 11/14/2019

… an overall medication adherence rate of 93% alongside strong treatment outcomes. November 14, 2019 Share A new study suggests that Proteus Digital Health’s sensor-embedded pills can improve adherence among Hepatitis C (HCV) patients who … significant impact on curing patients at high risk of nonadherence,” Andrew Thompson, CEO of Proteus Digital Health, said in a statement. “As we pursue the use of DigiMeds across therapeutic areas, we believe we will …

Medication Adherence

HCV patients at risk of nonadherence using Proteus’ digital pill achieve sustained viral clearance | MobiHealthNews | 11/14/2019

The multi-center, single-arm, open-label study recorded an overall medication adherence rate of 93% alongside strong treatment outcomes. November 14, 2019 Share A new study suggests that Proteus Digital Health’s sensor-embedded pills … significant impact on curing patients at high risk of nonadherence,” Andrew Thompson, CEO of Proteus Digital Health, said in a statement. “As we pursue the use of DigiMeds across therapeutic areas, we believe we will …

Akili Interactive

Digital Medicine Changemakers Are Center Stage at CNS Summit 2017: Otsuka and Proteus, Akili Interactive Labs, and Pear Therapeutics to Receive CNS Summit 2017 Innovation Awards | PR Newswire | 11/17/2017

Worldwide Offices Digital Medicine Changemakers Are Center Stage at CNS Summit 2017: Otsuka and Proteus, Akili Interactive Labs, and Pear Therapeutics to Receive CNS Summit 2017 Innovation Awards The awardees are pioneers in Digital Medicine … William Carson , CEO of Otsuka Pharmaceutical Co., Ltd. (Otsuka), and Andrew Thompson , president and CEO of Proteus Digital Health (Proteus) Eddie Martucci , CEO, and Adam Gazzaley , Chief Scientific Advisor, Akili Interactive Labs, and Bakul Patel …

American Heart Association

Brainstorm Health: Digital Pill, FDA Kratom Warning, Hypertension Guidelines | Yahoo News | 11/15/2017

… of their habits—is one of the pillars of the digital health revolution . “Drug pricing is not the problem,” as Andrew Thompson, co-founder and CEO of Proteus, explained during Fortune ‘s second annual Brainstorm … detect hypertension and sleep apnea. A study presented at the American Heart Association’s (AHA) ongoing meeting in Anaheim suggests that Cardiogram’s deep neural network tech, called “DeepHeart,” could allow the Apple Watch to detect high …

Kaiser Permanente

First drug OK’d with Peninsula company’s digital tracker | The Business Journals | 11/14/2017

… to treat because family members and caregivers often can’t verify that they’ve actually taken the medicine. Proteus cofounder and CEO Andrew Thompson wasn’t immediately available to comment. But Chief Platform Officer David O’Reilly told the … Ltd., Chinese private equity firm Yuan Capital, the Carlyle Group, Kaiser Permanente, Otsuka Swiss partner Novartis International AG (NYSE: NVS), Medtronic plc (NYSE: MDT) and Asset Management Ventures …

Rock Health

GO-Biz Launches Cyber-Health IT Advisory Board with USC Center for Body Computing | PR Newswire | 11/2/2017

… Wainwright Fishburn, Global Head, Digital Health, Cooley LLP; John Mattison , MD, chief medical informatics officer at Kaiser Permanente, SCAL; and Andrew Thompson , chief executive officer of Proteus Digital Health. The advisory board is scheduled to … was recognized as the nation’s “Most Tech Savvy Doctor” by Rock Health. For more information about the USC CBC: uscbodycomputing.org View original content with multimedia: http://www.prnewswire.com/news-releases/go-biz-launches-cyber-health-it …

Keck Medicine of USC

GO-Biz Launches Cyber-Health IT Advisory Board with USC Center for Body Computing | PR Newswire | 11/2/2017

… Wainwright Fishburn, Global Head, Digital Health, Cooley LLP; John Mattison , MD, chief medical informatics officer at Kaiser Permanente, SCAL; and Andrew Thompson , chief executive officer of Proteus Digital Health. The advisory board is scheduled to … Body Computing is the digital health innovation center for the Keck Medicine of USC medical enterprise. Collaborating with inventors, strategists, designers, investors and visionaries from health care, entertainment and technology, the USC CBC serves as …